Aptamers Market by type - (Peptide aptamers, Nucleic Acid aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), by Application - (Therapeutics Development, Diagnostics, Research and Development), by End users - (Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
The Global Aptamers Market was worth $ 128.03 million in 2016 and estimated to reach $ 293 million by the end of 2021 with a growing potential of 18.00 %. Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity.
Aptamers are generated quickly and applied in the inhibition, characterization of proteins and for specific detection. Aptamers can be used as pharmaceutical leads, functional proteomic levels with antibodies, detection reagents, and small molecules.
Aptamers can be engineered to have higher specificity and affinity for number of targets.
Browse market data tables and in-depth TOC of the Global Aptamers Market to 2021 at www.marketdataforecast.com/market-…mers-market-1134/
The enormous opportunities offered by the market for the key players are the drug discovery, biomarker discovery, and diagnostics segments. The launch of Macugen, the first aptamer drug and the first diagnostic test for testing mycotoxins in grains has recognised the potential of aptamers in diagnostics and therapeutics.
So, the global market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis.
The major factor driving the growth of the market are technological advancements, increasing R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy in binding to large molecules compared to antibodies and the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX) will boost this market positively. Stringent regulations in use of aptamers, Ethical issues of the aptamers that are obtained from the animals, slow in reaching the market place owing to regulatory hurdles are hindering the growth of the market.
The Global Aptamers Market is broadly categorized based on type into Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.
DNA Based Aptamers has the highest share in the market and XNA based Aptamers accounts to have highest CAGR over the forecast period.
Based on Application the market is categorized into Therapeutics Development, Diagnostics, Research and Development and on the basis of end users the market is segmented into Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres.
Global Aptamers Market Geographical Analysis
- North America
- Latin America
- Middle East & Africa
North America dominates the global Aptamers market with highest share followed by Europe, Asia - Pacific. Asia-Pacific is expected to account highest growth during the forecast period.
Global Aptamers Market Leaders' Analysis
- AM Biotechnologies
- Aptamer Sciences Inc.
- Aptamer Solutions Ltd
- Aptus Biotech S.L.
- Base Pair Biotechnologies Inc
- NeoVentures Biotechnology Inc.
- SomaLogic Inc
- TriLink BioTechnologies Inc
- Vivonics, Inc
Category: Market Research Publishers and RetailersCompany about: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: